Comparison of intestinal metabolism for CYP3A substrates between rats and humans

被引:0
|
作者
Kadono, Keitaro [1 ]
Naritomi, Yoichi [1 ]
Tabata, Kenji [1 ]
机构
[1] Astellas Pharma Inc, Ibaraki, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P208
引用
收藏
页码:137 / 137
页数:1
相关论文
共 50 条
  • [41] Role of CYP3A in Isoniazid Metabolism In Vivo
    Liu, Ke
    Li, Feng
    Lu, Jie
    Gao, Zhiwei
    Klaassen, Curtis D.
    Ma, Xiaochao
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (02) : 219 - 222
  • [42] Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail
    Lee, Eunyoung
    Shon, Jong Cheol
    Liu, Kwang-Hyeon
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (06) : 366 - 372
  • [43] Danazol increases the oral bioavailability of midazolam by inactivation of hepatic and intestinal CYP3A in rats
    Fukuno, Shuhei
    Nagai, Katsuhito
    Kurotobi, Akemi
    Sahori, Yuki
    Nakagawa, Ryo
    Nomura, Rena
    Ito, Takuya
    Konishi, Hiroki
    XENOBIOTICA, 2023, 53 (05) : 421 - 428
  • [44] Decreased intestinal CYP3A and p-glycoprotein activities in rats with adjuvant arthritis
    Uno, Satoshi
    Kawase, Atsushi
    Tsuji, Akiko
    Tanino, Tadatoshi
    Iwaki, Masahiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (04) : 313 - 321
  • [45] Effect of glycyrrhizin on the activity of CYP3A enzyme in humans
    Tu, Jiang-Hua
    He, Yi-Jing
    Chen, Yao
    Fan, Lan
    Zhang, Wei
    Tan, Zhi-Rong
    Huang, Yuan-Fei
    Guo, Dong
    Hu, Dong-Li
    Wang, Dan
    Zhou, Hong-Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (08) : 805 - 810
  • [46] Effect of glycyrrhizin on the activity of CYP3A enzyme in humans
    Jiang-Hua Tu
    Yi-Jing He
    Yao Chen
    Lan Fan
    Wei Zhang
    Zhi-Rong Tan
    Yuan-Fei Huang
    Dong Guo
    Dong-Li Hu
    Dan Wang
    Hong-Hao Zhou
    European Journal of Clinical Pharmacology, 2010, 66 : 805 - 810
  • [47] Assessment of the hepatic and intestinal first-pass metabolism of midazolam in a CYP3A drug-drug interaction model rats
    Kanazu, T
    Okamura, N
    Yamaguchi, Y
    Baba, T
    Koike, M
    XENOBIOTICA, 2005, 35 (04) : 305 - 317
  • [48] The limited impact of CYP3A5 genotype for the pharmacokinetics of CYP3A substrates
    Burk, Oliver
    Schwab, Matthias
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (12) : 1097 - 1098
  • [49] The limited impact of CYP3A5 genotype for the pharmacokinetics of CYP3A substrates
    Oliver Burk
    Matthias Schwab
    European Journal of Clinical Pharmacology, 2007, 63 : 1097 - 1098
  • [50] Interactions of Orthosiphon stamineus and Morinda citrifolia with hepatic aminopyrine metabolism by CYP3A in rats
    Chin, J. H.
    Mahfoudh, M.
    Abas, H. H.
    PHARMACOGNOSY MAGAZINE, 2009, 5 (17) : 55 - 60